May. 5 at 11:57 AM
$SOPH Q1 '26 Earnings Results & Recap
• Reported GAAP EPS of -
$0.27 down -3.85% YoY
• Reported revenue of
$21.69M up 21.99% YoY
• SOPHIA GENETICS reaffirms FY2026 revenue guidance of
$92M to
$94M, reflecting 20%-22% year-over-year growth, and projects an Adjusted EBITDA loss between
$29M and
$32M, an improvement from FY2025.
